The Sahlgrenska University Hospital is a hospital network associated with the Sahlgrenska Academy at the University of Gothenburg in Gothenburg, Sweden. With 17,000 employees the hospital is the largest hospital in Sweden by a considerable margin, and the second largest hospital in Europe.

There are 2,000 beds in Sahlgrenska University Hospital.

During the past decade, Sahlgrenska University Hospital conducted 362 clinical trials. In the 10-year time frame, 362 clinical trials started and 84 clinical trials were completed, i.e. on average, 23.2% percent of trials that started reached the finish line to date. In the past 5 years, 180 clinical trials started and 49 clinical trials were completed. i.e. 27.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sahlgrenska University Hospital" #1 sponsor was "Sahlgrenska University Hospital, Sweden" with 76 trials, followed by "Göteborg University" with 45 trials sponsored, "Vastra Gotaland Region" with 29 trials sponsored, "Karolinska Institutet" with 19 trials sponsored and "Boehringer Ingelheim" with 19 trials sponsored. Other sponsors include 354 different institutions and companies that sponsored additional 201 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sahlgrenska University Hospital" #1 collaborator was "Sahlgrenska University Hospital, Sweden" with 51 trials as a collaborator, "Karolinska University Hospital" with 25 trials as a collaborator, "Skane University Hospital" with 18 trials as a collaborator, "Göteborg University" with 16 trials as a collaborator and "University Hospital, Linkoeping" with 15 trials as a collaborator. Other collaborators include 604 different institutions and companies that were collaborators in the rest 410 trials.

According to Clinical.Site data, the most researched conditions in "Sahlgrenska University Hospital" are "Breast Cancer" (23 trials), "Multiple Myeloma" (13 trials), "Atrial Fibrillation" (11 trials), "Obesity" (10 trials) and "Heart Failure" (9 trials). Many other conditions were trialed in "Sahlgrenska University Hospital" in a lesser frequency.

Most popular intervention types in "Sahlgrenska University Hospital" are "Drug" (254 trials), "Procedure" (91 trials), "Other" (78 trials), "Device" (66 trials) and "Biological" (33 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (64 trials), "Dexamethasone" (8 trials), "Bortezomib" (5 trials), "Lenalidomide" (5 trials) and "placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "Sahlgrenska University Hospital" are 474 trials for "All" genders, 47 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 228 active trials in "Sahlgrenska University Hospital". 3 are not yet recruiting, 152 are recruiting, 69 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 242 completed trials in Sahlgrenska University Hospital, 3 suspended trials, and 32 terminated clinical trials to date.

Out of the total trials that were conducted in Sahlgrenska University Hospital, 23 "Phase 1" clinical trials were conducted, 84 "Phase 2" clinical trials and 164 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 25 trials, and there were also 154 trials that are defined as “Not Applicable".

Sahlgrenska University Hospital has several departments that took part in Clinical trials: "Sahlgrenska Universitetssjukhuset; Jubileumskliniken" - 5 trials, "Sahlgrenska Sjukhuset; Neurology" - 4 trials, "Sahlgrenska Universitetssjukhuset; Onkology" - 3 trials, "Sahlgrens hospital, Department of Hematology" - 2 trials, "The Queen Silvia Children's Hospital, Sahlgrenska University Hospital" - 2 trials, "Vastra Gotaland Region, Sahlgrenska University Hospital, Department of Ophthalmology" - 2 trials, "Kardiologen" - 2 trials, "Clinical Rheumatology Research Center (CRRC), Department of Rheumatology, Sahlgrenska University Hospital" - 2 trials